Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 May;106(1):222–226. doi: 10.1111/j.1476-5381.1992.tb14318.x

Effects of a new pteridine derivative on urinary sodium, potassium and magnesium excretion in conscious saline-loaded rats.

T Netzer 1, F Ullrich 1, H Priewer 1, M Majewski 1, E Mutschler 1
PMCID: PMC1907469  PMID: 1504728

Abstract

1. Two recently synthesized pteridine derivatives (RPH 3036; RPH 3038) were tested in conscious saline-loaded rats and showed natriuretic and antimagnesiuretic properties but hardly reduced potassium excretion. 2. In the same model a dose-response curve was performed for RPH 3036. ED50 and Emax values were calculated for the natriuretic (ED50 = 13.4 mumol kg-1; Emax = 1.08 mmol kg-1) and antimagnesiuretic (ED50 = 11.3 mumol kg-1; Emax = -0.099 mmol kg-1) properties of RPH 3036. There were no significant changes of potassium and calcium excretion. 3. After a single dose of RPH 3036 (100 mumol kg-1) the time course of electrolyte excretion was analysed over 6 h. RPH 3036 did not show any significant effects on renal potassium and calcium excretion whereas a pronounced decrease (P less than 0.01) in renal magnesium excretion was evident during the 6 h. A moderate increase of sodium excretion was observed only after 3, 5 and 6 h. 4. A selective reduction of magnesium secretion in the late distal tubule and collecting duct was proposed as a possible mechanism of action of RPH 3036. This would explain the fast onset of action as well as the lack of antikaliuretic and anticalciuretic effects. The high selectivity of RPH 3036 makes it potentially valuable for the future investigation of renal magnesium transport.

Full text

PDF
222

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alfredson K. S., Walser M. Is magnesium secreted by the rat renal tubule? Nephron. 1970;7(3):241–247. doi: 10.1159/000179826. [DOI] [PubMed] [Google Scholar]
  2. Devane J., Ryan M. P. Evidence for a magnesium-sparing action by amiloride during renal clearance studies in rats. Br J Pharmacol. 1983 Aug;79(4):891–896. doi: 10.1111/j.1476-5381.1983.tb10533.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Devane J., Ryan M. P. The effects of amiloride and triamterene on urinary magnesium excretion in conscious saline-loaded rats. Br J Pharmacol. 1981 Feb;72(2):285–289. doi: 10.1111/j.1476-5381.1981.tb09127.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dyckner T., Wester P. O. Intracellular magnesium loss after diuretic administration. Drugs. 1984 Oct;28 (Suppl 1):161–166. doi: 10.2165/00003495-198400281-00016. [DOI] [PubMed] [Google Scholar]
  5. Dyckner T., Wester P. O., Widman L. Effects of spironolactone on serum and muscle electrolytes in patients on long-term diuretic therapy for congestive heart failure and/or arterial hypertension. Eur J Clin Pharmacol. 1986;30(5):535–540. doi: 10.1007/BF00542411. [DOI] [PubMed] [Google Scholar]
  6. Hendry B. M., Ellory J. C. Molecular sites for diuretic action. Trends Pharmacol Sci. 1988 Nov;9(11):416–421. doi: 10.1016/0165-6147(88)90070-3. [DOI] [PubMed] [Google Scholar]
  7. Hänze S., Seyberth H. Untersuchungen zur Wirkung der Diuretica Furosemid, Etacrynsäure und Triamteren auf die renale Magnesium- und Calciumaussecheidung. Klin Wochenschr. 1967 Mar 15;45(6):313–314. doi: 10.1007/BF01747104. [DOI] [PubMed] [Google Scholar]
  8. Leary W. P., Reyes A. J. Diuretic-induced magnesium losses. Drugs. 1984 Oct;28 (Suppl 1):182–187. doi: 10.2165/00003495-198400281-00018. [DOI] [PubMed] [Google Scholar]
  9. Lim P., Jacob E. Magnesium-saving property of an aldosterone antagonist in the treatment of oedema of liver cirrhosis. Br Med J. 1978 Mar 25;1(6115):755–756. doi: 10.1136/bmj.1.6115.755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Massry S. G., Coburn J. W., Kleeman C. R. Renal handling of magnesium in the dog. Am J Physiol. 1969 Jun;216(6):1460–1467. doi: 10.1152/ajplegacy.1969.216.6.1460. [DOI] [PubMed] [Google Scholar]
  11. Priewer H., Wolf E., Kraft H., Knauf H., Mutschler E. Dissociation of the natriuretic and antikaliuretic properties of triamterene derivatives by dose-response experiments. Pharm Res. 1987 Feb;4(1):66–69. doi: 10.1023/a:1016490113355. [DOI] [PubMed] [Google Scholar]
  12. Ryan M. P., Devane J., Ryan M. F., Counihan T. B. Effects of diuretics on the renal handling of magnesium. Drugs. 1984 Oct;28 (Suppl 1):167–181. doi: 10.2165/00003495-198400281-00017. [DOI] [PubMed] [Google Scholar]
  13. Ryan M. P. Magnesium and potassium-sparing diuretics. Magnesium. 1986;5(5-6):282–292. [PubMed] [Google Scholar]
  14. Widmann L., Dyckner T., Wester P. O. Effects of triamterene on serum and skeletal muscle electrolytes in diuretic-treated patients. Eur J Clin Pharmacol. 1988;33(6):577–579. doi: 10.1007/BF00542490. [DOI] [PubMed] [Google Scholar]
  15. van Meyel J. J., Smits P., Gribnau F. W. Absence of magnesium sparing effect of a single dose of triamterene in combination with frusemide in healthy male adults. Br J Clin Pharmacol. 1990 Nov;30(5):774–777. doi: 10.1111/j.1365-2125.1990.tb03849.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES